Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma
Liangqing Dong, Dayun Lu, Ran Chen, et al.
Cancer Cell (2021) Vol. 40, Iss. 1, pp. 70-87.e15
Closed Access | Times Cited: 222

Showing 1-25 of 222 citing articles:

Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity
Ryan C. Gimple, Kailin Yang, Matthew Halbert, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 9, pp. 497-514
Closed Access | Times Cited: 86
Immunology and immunotherapy of cholangiocarcinoma
Tim F. Greten, Robert F. Schwabe, Nabeel Bardeesy, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 85
Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications
Miguel A. Martín-Serrano, Benjamin Kepecs, Miguel Torres‐Martín, et al.
Gut (2022) Vol. 72, Iss. 4, pp. 736-748
Open Access | Times Cited: 84
Proteogenomic data and resources for pan-cancer analysis
Yize Li, Yongchao Dou, Felipe da Veiga Leprevost, et al.
Cancer Cell (2023) Vol. 41, Iss. 8, pp. 1397-1406
Open Access | Times Cited: 82
Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies
Qian Liu, Jing Zhang, Chenchen Guo, et al.
Cell (2024) Vol. 187, Iss. 1, pp. 184-203.e28
Open Access | Times Cited: 61
Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology
Shuyi Ji, Feng Li, Zile Fu, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 706
Closed Access | Times Cited: 52
Metabolic reprogramming in the tumor microenvironment of liver cancer
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 35
Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer
Hui Yang, Jinghui Cheng, Hao Zhuang, et al.
Cancer Cell (2024) Vol. 42, Iss. 4, pp. 535-551.e8
Open Access | Times Cited: 27
Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD
Yang Long, Kunwei Niu, Jianlin Wang, et al.
Journal of Hepatology (2024)
Open Access | Times Cited: 25
Pan-cancer proteogenomics expands the landscape of therapeutic targets
Sara R. Savage, Xinpei Yi, Jonathan T. Lei, et al.
Cell (2024) Vol. 187, Iss. 16, pp. 4389-4407.e15
Open Access | Times Cited: 22
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity
Meng‐Ju Wu, Hiroshi Kondo, Ashwin V. Kammula, et al.
Science (2024) Vol. 385, Iss. 6705
Closed Access | Times Cited: 15
Adjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma
Jeremy Sharib, Kristen E. Rhodin, Annie Liu, et al.
Annals of Surgical Oncology (2025) Vol. 32, Iss. 4, pp. 2456-2466
Closed Access | Times Cited: 1
Proteomic and phosphoproteomic landscapes of acute myeloid leukemia
Michael H. Kramer, Qiang Zhang, Robert W. Sprung, et al.
Blood (2022) Vol. 140, Iss. 13, pp. 1533-1548
Open Access | Times Cited: 62
Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target
Giorgia Alvisi, Alberto Termanini, Cristiana Soldani, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 5, pp. 1359-1372
Open Access | Times Cited: 60
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment
Yu-Heng Zhu, Jia-Hao Zheng, Qin-Yuan Jia, et al.
Cellular Oncology (2022) Vol. 46, Iss. 1, pp. 17-48
Closed Access | Times Cited: 56
Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science
Kentaro Inamura, Tsuyoshi Hamada, Susan Bullman, et al.
Gut (2022) Vol. 71, Iss. 10, pp. 2107-2122
Open Access | Times Cited: 50
Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma
Youpei Lin, Lihua Peng, Liangqing Dong, et al.
Cancer Discovery (2022) Vol. 12, Iss. 10, pp. 2350-2371
Open Access | Times Cited: 50
Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell RNA Sequencing–Assisted Multiomics Analysis
Xuanwen Bao, Qiong Li, Jinzhang Chen, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 7, pp. 811-828
Open Access | Times Cited: 48
Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities
Jian Lin, Yuting Dai, Chen Sang, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004892-e004892
Open Access | Times Cited: 46
SLC1A1-mediated cellular and mitochondrial influx of R-2-hydroxyglutarate in vascular endothelial cells promotes tumor angiogenesis in IDH1-mutant solid tumors
Xiaomin Wang, Ziqi Chen, Jun Xu, et al.
Cell Research (2022) Vol. 32, Iss. 7, pp. 638-658
Open Access | Times Cited: 40
METTL3 protects METTL14 from STUB1‐mediated degradation to maintain m6A homeostasis
Zhan‐Cheng Zeng, Qi Pan, Yu‐Meng Sun, et al.
EMBO Reports (2023) Vol. 24, Iss. 3
Open Access | Times Cited: 30
Proteomics of adjacent-to-tumor samples uncovers clinically relevant biological events in hepatocellular carcinoma
Hongwen Zhu, Youpei Lin, Dayun Lu, et al.
National Science Review (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 30
Integrative proteomic characterization of adenocarcinoma of esophagogastric junction
Shengli Li, Yuan Li, Zhiyuan Xu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 28
Development and validation of a new prognostic immune–inflammatory–nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study
Jiang Zhu, Denghui Wang, Chang Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
HKDC1 reprograms lipid metabolism to enhance gastric cancer metastasis and cisplatin resistance via forming a ribonucleoprotein complex
Ping Zhao, Fei Yuan, Lijuan Xu, et al.
Cancer Letters (2023) Vol. 569, pp. 216305-216305
Closed Access | Times Cited: 25
Page 1 - Next Page

Scroll to top